Market Cap 50.52B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 15.66
Forward PE 14.73
Profit Margin 0.48%
Debt to Equity Ratio 3.45
Volume 1,795,300
Avg Vol 1,673,044
Day's Range N/A - N/A
Shares Out 194.53M
Stochastic %K 25%
Beta 0.64
Analysts Strong Sell
Price Target $379.00

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distr...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
BillionerOfKing
BillionerOfKing May. 12 at 1:40 PM
$COR Current Stock Price: $259.70 Contracts to trade: $260.0 COR May 15 2026 Call Entry: $3.60 Exit: $5.51 ROI: 53% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
1 · Reply
yahav526
yahav526 May. 12 at 9:06 AM
0 · Reply
MarketBeat
MarketBeat May. 9 at 9:05 PM
https://marketbeat.com/a/8644501/ $COR Cencora Q2 Earnings Call Highlights
0 · Reply
RenHenInvestments
RenHenInvestments May. 6 at 2:52 PM
$MCK $COR is bringing this down today, they usually trade in sympathy. Although I am buying MCK on this sell-off. $LLY reported an impressive beat and raise, and MCK is likely handling the majority of the volume. Let's not forget $UNH and $CVS are typically good read throughs for MCK as well, both had great earnings. I feel confident with MCK.
3 · Reply
ArkyCapital
ArkyCapital May. 6 at 2:33 PM
$CAH found the culprit... $COR shat the bed. Carry on $CAH.
0 · Reply
Arcides
Arcides May. 6 at 2:28 PM
$COR absolute garbage
0 · Reply
Cutlass
Cutlass May. 6 at 2:27 PM
$COR Placed on watch 👀✍️💊
0 · Reply
CrazyChief
CrazyChief May. 6 at 2:15 PM
$COR Added
0 · Reply
jhalimath61
jhalimath61 May. 6 at 1:57 PM
$COR Raised guidance and buybacks should help, pretty brutal drop but they will be fine long term.
0 · Reply
MorningMarkets
MorningMarkets May. 6 at 1:36 PM
$COR just realized I put Q1 instead of Q2… Damn, that did not go well. Guidance isn’t bad and 1B in buybacks over the rest of the fiscal year.
0 · Reply
Latest News on COR
Cencora price target lowered to $339 from $420 at Baird

2026-05-07T16:03:22.000Z - 5 days ago

Cencora price target lowered to $339 from $420 at Baird


Cencora price target raised to $412 from $410 at UBS

2026-05-07T13:27:00.000Z - 5 days ago

Cencora price target raised to $412 from $410 at UBS


Cencora price target lowered to $355 from $405 at Citi

2026-05-07T11:17:45.000Z - 6 days ago

Cencora price target lowered to $355 from $405 at Citi


Cencora reports Q2 adjusted EPS $4.75, consensus $4.73

2026-05-07T09:39:48.000Z - 6 days ago

Cencora reports Q2 adjusted EPS $4.75, consensus $4.73


Cencora Earnings Call Transcript: Q2 2026

May 6, 2026, 8:30 AM EDT - 7 days ago

Cencora Earnings Call Transcript: Q2 2026


Cencora raises annual profit forecast despite quarterly miss

May 6, 2026, 7:41 AM EDT - 7 days ago

Cencora raises annual profit forecast despite quarterly miss


Cencora Reports Fiscal 2026 Second Quarter Results

May 6, 2026, 6:30 AM EDT - 7 days ago

Cencora Reports Fiscal 2026 Second Quarter Results


Cencora initiated with a Market Perform at William Blair

2026-04-28T10:11:54.000Z - 15 days ago

Cencora initiated with a Market Perform at William Blair


Cencora CFO James Cleary to retire

2026-03-17T13:21:27.000Z - 2 months ago

Cencora CFO James Cleary to retire


Cencora Announces Financial Leadership Transition

Mar 17, 2026, 8:30 AM EDT - 2 months ago

Cencora Announces Financial Leadership Transition


Cencora Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 2:20 PM EDT - 2 months ago

Cencora Transcript: Leerink Global Healthcare Conference 2026


Cencora price target raised to $380 from $360 at BofA

2026-03-06T12:11:47.000Z - 2 months ago

Cencora price target raised to $380 from $360 at BofA


Cencora Transcript: AGM 2026

Mar 5, 2026, 3:30 PM EST - 2 months ago

Cencora Transcript: AGM 2026


Covetrus and MWI Animal Health to Merge

Feb 18, 2026, 7:00 AM EST - 3 months ago

Covetrus and MWI Animal Health to Merge


Cencora Closes $3.0 Billion Senior Notes Offering

Feb 13, 2026, 4:15 PM EST - 3 months ago

Cencora Closes $3.0 Billion Senior Notes Offering


Cencora price target raised to $425 from $400 at Barclays

2026-02-13T11:47:40.000Z - 3 months ago

Cencora price target raised to $425 from $400 at Barclays


Cencora price target raised to $419 from $417 at JPMorgan

2026-02-10T12:01:29.000Z - 3 months ago

Cencora price target raised to $419 from $417 at JPMorgan


Cencora price target raised to $429 from $405 at Wells Fargo

2026-02-10T11:41:44.000Z - 3 months ago

Cencora price target raised to $429 from $405 at Wells Fargo


Cencora Earnings Call Transcript: Q1 2026

Feb 4, 2026, 8:30 AM EST - 3 months ago

Cencora Earnings Call Transcript: Q1 2026


Cencora Reports Fiscal 2026 First Quarter Results

Feb 4, 2026, 6:30 AM EST - 3 months ago

Cencora Reports Fiscal 2026 First Quarter Results


Cencora Elects Ellen Cooper to Its Board of Directors

Jan 22, 2026, 7:30 AM EST - 3 months ago

Cencora Elects Ellen Cooper to Its Board of Directors


Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 4 months ago

Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference


Cencora Earnings Call Transcript: Q4 2025

Nov 5, 2025, 8:30 AM EST - 6 months ago

Cencora Earnings Call Transcript: Q4 2025


Cencora Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 3:45 PM EDT - 8 months ago

Cencora Transcript: Baird Global Healthcare Conference 2025


Cencora Earnings Call Transcript: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 10 months ago

Cencora Earnings Call Transcript: Q3 2025


Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 10 months ago

Cencora Reports Fiscal 2025 Third Quarter Results


Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 1 year ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors


Cencora Earnings Call Transcript: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings Call Transcript: Q2 2025


Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2025 Second Quarter Results


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 1 year ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM


Cencora Earnings Call Transcript: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings Call Transcript: Q1 2025


Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 1 year ago

Cencora raises 2025 profit forecast on specialty drug demand


Cencora Reports Fiscal 2025 First Quarter Results

Feb 5, 2025, 6:30 AM EST - 1 year ago

Cencora Reports Fiscal 2025 First Quarter Results


Cencora raises annual profit forecast

Jan 2, 2025, 4:23 PM EST - 1 year ago

Cencora raises annual profit forecast


Cencora Closes $1.8 Billion Senior Notes Offering

Dec 9, 2024, 4:15 PM EST - 1 year ago

Cencora Closes $1.8 Billion Senior Notes Offering


Cencora Transcript: Citi's 2024 Global Healthcare Conference

Dec 4, 2024, 9:30 AM EST - 1 year ago

Cencora Transcript: Citi's 2024 Global Healthcare Conference


Cencora to Host Inaugural Product Showcase

Nov 26, 2024, 8:30 AM EST - 1 year ago

Cencora to Host Inaugural Product Showcase


Cencora Earnings Call Transcript: Q4 2024

Nov 6, 2024, 8:30 AM EST - 1 year ago

Cencora Earnings Call Transcript: Q4 2024


Cencora to buy Retina Consultants of America for $4.6 bln

Nov 6, 2024, 6:54 AM EST - 1 year ago

Cencora to buy Retina Consultants of America for $4.6 bln


BillionerOfKing
BillionerOfKing May. 12 at 1:40 PM
$COR Current Stock Price: $259.70 Contracts to trade: $260.0 COR May 15 2026 Call Entry: $3.60 Exit: $5.51 ROI: 53% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
1 · Reply
yahav526
yahav526 May. 12 at 9:06 AM
0 · Reply
MarketBeat
MarketBeat May. 9 at 9:05 PM
https://marketbeat.com/a/8644501/ $COR Cencora Q2 Earnings Call Highlights
0 · Reply
RenHenInvestments
RenHenInvestments May. 6 at 2:52 PM
$MCK $COR is bringing this down today, they usually trade in sympathy. Although I am buying MCK on this sell-off. $LLY reported an impressive beat and raise, and MCK is likely handling the majority of the volume. Let's not forget $UNH and $CVS are typically good read throughs for MCK as well, both had great earnings. I feel confident with MCK.
3 · Reply
ArkyCapital
ArkyCapital May. 6 at 2:33 PM
$CAH found the culprit... $COR shat the bed. Carry on $CAH.
0 · Reply
Arcides
Arcides May. 6 at 2:28 PM
$COR absolute garbage
0 · Reply
Cutlass
Cutlass May. 6 at 2:27 PM
$COR Placed on watch 👀✍️💊
0 · Reply
CrazyChief
CrazyChief May. 6 at 2:15 PM
$COR Added
0 · Reply
jhalimath61
jhalimath61 May. 6 at 1:57 PM
$COR Raised guidance and buybacks should help, pretty brutal drop but they will be fine long term.
0 · Reply
MorningMarkets
MorningMarkets May. 6 at 1:36 PM
$COR just realized I put Q1 instead of Q2… Damn, that did not go well. Guidance isn’t bad and 1B in buybacks over the rest of the fiscal year.
0 · Reply
OpenOutcrier
OpenOutcrier May. 6 at 12:28 PM
$COR (-5.7% pre) Cencora (NYSE:COR) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings https://ooc.bz/l/101234
0 · Reply
jhalimath61
jhalimath61 May. 6 at 11:18 AM
$COR Gonna do what THC did and drop on good earnings only to fly the following couple days? Got it
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 10:39 AM
$COR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $8.44 up 128.11% YoY • Reported revenue of $78.36B up 3.85% YoY • Cencora raised its fiscal year 2026 adjusted diluted EPS guidance to a range of $17.65 to $17.90 and expects 4% to 6% revenue growth and 12% to 14% adjusted operating income growth.
0 · Reply
DidYouReadThis
DidYouReadThis Apr. 30 at 5:28 PM
$OTLK Was anyone surprised by Norse 8? Was week 12 surprising? $REGN $RHHBY $COR
2 · Reply
MorningMarkets
MorningMarkets Apr. 30 at 1:40 PM
$COR hope this surges right back up after Q1 results next week.
1 · Reply
DidYouReadThis
DidYouReadThis Apr. 29 at 5:27 PM
$DJT friends, do you think #TheDonald might help get $OTLK or any other pharma stocks get #FDA approved this year? $OTLK is #EMA approved. What percent of the time is bevacizumab used off label? Who sponsored the CATT Trial? What drug is commonly used for Medicare, Medicaid, and VA wet AMD patients? What’s the market size of #WetAMD? What’s the market cap of $OTLK? What’s the market cap of $COR? What’s the market cap of Regeneron and Roche? If $OTLK earns FDA approval, what do you estimate for the buy out price?
0 · Reply
jhalimath61
jhalimath61 Apr. 24 at 1:24 AM
$COR hope yall bought that dip. I loaded at 306
0 · Reply
Arcides
Arcides Apr. 22 at 4:34 PM
$COR health care names are acting bad...this could be coming to 270 level
0 · Reply
CrazyChief
CrazyChief Apr. 18 at 4:08 PM
0 · Reply
Sigmanomics
Sigmanomics Apr. 14 at 11:43 PM
Cencora’s Quiet Power: Consistent Growth in a Tight-Margin World - https://sigmanomics.com/cencoras-quiet-power $COR $SPY $ES_F $QQQ $PEP
0 · Reply
PanicSeller8
PanicSeller8 Apr. 9 at 2:02 PM
$CAH $MCK $COR Continue to add. Safety and growth.
3 · Reply
SuperGreenToday
SuperGreenToday Apr. 6 at 8:12 PM
$COR Share Price: $320.93 Contract Selected: Aug 21, 2026 $320 Calls Buy Zone: $20.82 – $25.73 Target Zone: $33.99 – $41.54 Potential Upside: 54% ROI Time to Expiration: 136 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply